The COVID-19 pandemic is a major threat to global health for which there are only limited
medical countermeasures, and we lack a thorough understanding of mechanisms of …

Mutations and transient conformational movements of the receptor binding domain (RBD)
that make neutralizing epitopes momentarily unavailable present immune escape routes for …

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
around the world, there is an urgent need for new assay formats to characterize the humoral …

ABSTRACT VIR-7831 and VIR-7832 are dual action monoclonal antibodies (mAbs)
targeting the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS …

As the number of people infected with the newly identified 2019 novel coronavirus (SARS-
CoV2) is continuously increasing every day, development of potential therapeutic platforms …

The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has posed serious threats to global health and …

An outbreak of coronavirus disease 2019 (COVID-19),–, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spread globally. Countermeasures are needed …

SUMMARY The SARS-coronavirus 2 (SARS-CoV-2) spike (S) protein mediates entry of
SARS-CoV-2 into cells expressing the angiotensin-converting enzyme 2 (ACE2). The S …

The infection of the novel coronavirus severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused more than 200 000 deaths, but no vaccine or therapeutic …

The worldwide spread of COVID-19 highlights the need for an efficient approach to rapidly
develop therapeutics and prophylactics against SARS-CoV-2. The SARS-CoV-2 spike …